MACROPHAGE PHARMA LIMITED logo — Empowering the immune system to combat cancer with precision...

MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

Founded 2014 Series A Total: $9.00M Biotechnology, Pharmaceutical

General Information

Company Name MACROPHAGE PHARMA LIMITED
Founded Year 2014
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when MACROPHAGE PHARMA LIMITED moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MACROPHAGE PHARMA LIMITED

MACROPHAGE PHARMA LIMITED is an immuno-oncology company established in 2014 with the slogan, "Empowering the immune system to combat cancer with precision-targeted therapies." Specializing in Biotechnology and Pharmaceutical industries, the company is dedicated to finding and developing new treatments to enhance anti-tumor immune responses. Macrophage Pharma's platform is designed to administer small molecule drugs directly to tumor-associated macrophages, thereby activating the body's natural immune system to fight against cancer. The company's most recent milestone was securing a £9.00M Series A investment on 09 January 2017 from prominent investors such as Novo Holdings, Aglaia Biomedical Ventures, MERL Ventures Fund, and SIXTH ELEMENT CAPITAL LLP.

Taxonomy: immuno-oncology, cancer treatment, immune system, precision-targeted therapies, tumor-associated macrophages, small molecule drugs, treatment discovery, immune response activation, tumor therapy, novel therapies, immune system enhancement, anti-tumor immune responses, drug delivery technology, cancer research, biopharmaceutical company

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor Investor
09 Jan 2017

MACROPHAGE PHARMA LIMITED Alternatives & Competitors

MACROPHAGE PHARMA LIMITED vs

Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.

Post Ipo Equity
14 employees
Biopharma, Biotechnology
MACROPHAGE PHARMA LIMITED vs

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengine...

Series C
9 employees
Biopharma, Biotechnology
MACROPHAGE PHARMA LIMITED vs
VerImmune
VerImmune United States

Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer

Seed
13 employees
Biotechnology, Health Care

FAQ About MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies
MACROPHAGE PHARMA LIMITED was founded in 2014.
MACROPHAGE PHARMA LIMITED operates in the following industries: Biotechnology, Pharmaceutical.
MACROPHAGE PHARMA LIMITED has completed 1 funding round, raising a total of $9.00M. The latest funding stage is Series A.
Top alternatives and competitors to MACROPHAGE PHARMA LIMITED include Trillium Therapeutics Inc., Umoja Biopharma, VerImmune, Immunowake, Inc., Navrogen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MACROPHAGE PHARMA LIMITED and Trillium Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MACROPHAGE PHARMA LIMITED and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy